Your Health. Your Family. Your Choice.
Administered by: Other Purchased by: ?
Life Threatening? No
Write-up: Died within 4 hours; This is a spontaneous report from a contactable other hcp downloaded from the Regulatory Authority -WEB [NL-LRB-00535361]. A 69-year-old male patient received bnt162b2 (COMIRNATY), via an unspecified route of administration on 28Apr2021 (Batch/Lot Number: ET6956) as 1st dose, single for covid-19 immunisation; Acenocoumarol via an unspecified route of administration from 2020 to 28Apr2021, according to scheme for an unspecified indication. Medical history included diabetes mellitus, obesity (BMI=31), heart failure, cardiac fibrillation from 2020. No Previous COVID-19 infection. Concomitant medication included Insulin. The patient experienced died within 4 hours (Heart attack) on 28Apr2021. Action taken for Acenocoumarol was unknown. The outcome of heart attack is fatal. It was not reported if an autopsy was performed. No follow-up attempts possible. No further information expected. ; Reporter''s Comments: BioNTech / Pfizer vaccine (Comirnaty) Past drug therapy BioNTech / Pfizer vaccine (Comirnaty): no confounding factors confounding factors: Diabetes and heart failure COVID-19 Previous COVID-19 infection: No.; Reported Cause(s) of Death: Died within 4 hours
Copyright © 2022 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166